Ipilimumab and nivolumab: the 'new kid on the block' in advanced angiosarcoma.

Immunotherapy

Division of International Patients Care, Gustave Roussy Cancer Campus, Villejuif, France.

Published: October 2023

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2023-0110DOI Listing

Publication Analysis

Top Keywords

ipilimumab nivolumab
4
nivolumab 'new
4
'new kid
4
kid block'
4
block' advanced
4
advanced angiosarcoma
4
ipilimumab
1
'new
1
kid
1
block'
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!